Related Experiment Video
Updated: Jun 9, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
[Treatment of chronic hepatitis B and C - update 2010]
J C Mertens1, A Geier, B Müllhaupt
1Swiss HPB (Hepato-Pancreato-Biliary) Center, Klinik für Gastroenterologie und Hepatologie, Universitätsspital Zürich, Zürich.
Abstract:
The treatment of chronic hepatitis C and B has become more and more complex over the last years. Individualisation of therapy, depending of the natural history as well as on treatment response, is increasingly finding its way into clinical practice. In addition, a significant number of new molecules active, against the hepatitis C virus, are currently in clinical evaluation. The goal of this review is to provide an up-to-date overview on the current treatment options for patients with a chronic viral hepatitis.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Chronic Pancreatitis II: Collaborative Care
Assessment:
Inhibitors of Viral Protein Synthesis
Cirrhosis I: Introduction
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...